LR11: A novel biomarker identified in follicular lymphoma

British Journal of Haematology

Volumn 163, Issue 2, 2013, Pages 277-280

  Kawaguchi, Takeharu ^a   Ohwada, Chikako ^a   Takeuchi, Masahiro ^a   Shimizu, Naomi ^a   Sakaida, Emiko ^a   Takeda, Yusuke ^a   Sakai, Shio ^a   Tsukamoto, Shokichi ^a   Yamazaki, Atsuko ^a   Sugita, Yasumasa ^a   Jiang, Meizi ^b   Higashi, Morihiro ^c   Yokote, Koutaro ^d   Tamaru, Jun ichi ^c   Bujo, Hideaki ^b   Nakaseko, Chiaki ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; FLIPI 2; Follicular lymphoma; LR11; Progression free survival

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMOGLOBIN; LR11 PROTEIN; MEMBRANE PROTEIN; PREDNISOLONE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

BLOOD SAMPLING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UNIVERSITY HOSPITAL;

BIOMARKER; FLIPI-2; FOLLICULAR LYMPHOMA; LR11; PROGRESSION FREE SURVIVAL;

BIOLOGICAL MARKERS; BIOPSY; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LYMPH NODES; LYMPHOMA, FOLLICULAR; MEMBRANE TRANSPORT PROTEINS; PROGNOSIS;

EID: 84884989365     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12467     Document Type: Letter

References (10)

1. Federico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., Cortelazzo, S., Martinelli, G., Martelli, M., Rigacci, L., Arcaini, L., Di Raimondo, F., Merli, F., Sabattini, E., McLaughlin, P. & Solal-Celigny, P. (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. Journal of Clinical Oncology, 27, 4555-4562.
2. Jiang, M., Bujo, H., Ohwaki, K., Unoki, H., Yamazaki, H., Kanaki, T., Shibasaki, M., Azuma, K., Harigaya, K., Schneider, W.J. & Saito, Y. (2008) Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. Journal of Clinical Investigation, 118, 2733-2746.
3. Matsuo, M., Ebinuma, H., Fukamachi, I., Jiang, M., Bujo, H. & Saito, Y. (2009) Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis. Clinical Chemistry, 55, 1801-1808.
4. Nishii, K., Nakaseko, C., Jiang, M., Shimizu, N., Takeuchi, M., Schneider, W.J. & Bujo, H. (2013) The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type Plasminogen Activator Receptor (uPAR)-mediated adhesion of immature hematological cells. Journal of Biological Chemistry, 288, 11877-11886.
5. Ohwaki, K., Bujo, H., Jiang, M., Yamazaki, H., Schneider, W.J. & Saito, Y. (2007) A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1050-1056.
6. Sakai, S., Nakaseko, C., Takeuchi, M., Ohwada, C., Shimizu, N., Tsukamoto, S., Kawaguchi, T., Jiang, M., Sato, Y., Ebinuma, H., Yokote, K., Iwama, A., Fukamachi, I., Schneider, W.J., Saito, Y. & Bujo, H. (2012) Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clinica Chimica Acta, 413, 1542-1548.
7. Salles, G. & Ghesquieres, H. (2012) Current and future management of follicular lymphoma. International Journal of Hematology, 96, 544-551.
8. Takahashi, M., Bujo, H., Jiang, M., Noike, H., Saito, Y. & Shirai, K. (2010) Enhanced circulating soluble LR11 in patients with coronary organic stenosis. Atherosclerosis, 210, 581-584.
9. Weekes, C.D., Kuszynski, C.A. & Sharp, J.G. (2001) VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells. Leukaemia & Lymphoma, 40, 631-645.
10. Zhang, X., Dormady, S.P. & Basch, R.S. (2000) Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors. Experimental Hematology, 28, 1286-1296.